Insulet Announces Omnipod® 5 System is Now Compatible with Abbott's FreeStyle Libre 2 Plus Sensor in the U.S. [Yahoo! Finance]
Insulet Corporation (PODD)
Last insulet corporation earnings: 2/25 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.insulet.com/investor-relations
Company Research
Source: Yahoo! Finance
pump technology with its Omnipod® brand of products, today announced the Omnipod 5 Automated Insulin Delivery (AID) System is now compatible with Abbott's FreeStyle Libre 2 Plus continuous glucose monitoring (CGM) sensor in the U.S. This makes Omnipod 5 the most connected tubeless AID system in the U.S. "We are excited to announce that Omnipod 5, the only AID system indicated for both type 1 and type 2 diabetes, is now integrated with Abbott's FreeStyle Libre 2 Plus sensor in the U.S. This latest innovation will allow millions of Americans who take insulin the ability to get started on Pod therapy using their preferred CGM sensor," said Eric Benjamin, Insulet's Executive Vice President and Chief Product and Customer Experience Officer. "As we work to reach more people with our innovative, tubeless Omnipod 5 AID System, today's announcement represents yet another significant step forward for our Company and our customers." The Omnipod 5 System simplifies diabetes management and has
Show less
Read more
Impact Snapshot
Event Time:
PODD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PODD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PODD alerts
High impacting Insulet Corporation news events
Weekly update
A roundup of the hottest topics
PODD
News
- Insulet Corporation (NASDAQ:PODD) Delivered A Better ROE Than Its Industry [Yahoo! Finance]Yahoo! Finance
- Insulet Co. (NASDAQ: PODD) had its price target raised by analysts at JPMorgan Chase & Co. from $280.00 to $330.00. They now have an "overweight" rating on the stock.MarketBeat
- Insulet Co. (NASDAQ: PODD) had its price target raised by analysts at Citigroup Inc. from $283.00 to $310.00. They now have a "buy" rating on the stock.MarketBeat
- Insulet Co. (NASDAQ: PODD) had its price target raised by analysts at Wells Fargo & Company from $290.00 to $305.00. They now have an "overweight" rating on the stock.MarketBeat
- Insulet Co. (NASDAQ: PODD) had its price target raised by analysts at Canaccord Genuity Group Inc. from $269.00 to $304.00. They now have a "buy" rating on the stock.MarketBeat
PODD
Earnings
- 11/7/24 - Beat
PODD
Sec Filings
- 12/17/24 - Form 4
- 12/16/24 - Form 144
- 12/11/24 - Form 4
- PODD's page on the SEC website